Morning Briefing
Summaries of health policy coverage from major news organizations
Viewpoints: First Political Battles Of 2027 Should Tackle Medicaid, RFK Jr. Impeachment; Measles Deaths Are A Preventable Tragedy
Bloomberg: Medicaid Expansion Will Be The First Big Political Fight Of 2027
November’s big Democratic wins in state races could empower the party to close the largest remaining gap in America’s healthcare safety net: Medicaid, the joint state-federal program providing healthcare for low-income Americans. Ten states have long refused to expand it, and Democrats have new power in several of them, including Texas, Georgia and Wisconsin. (Ronald Brownstein, 11/17)
Stat: Why Now Is The Time To Impeach HHS Secretary Robert Kennedy Jr.
The midterms didn’t just bring a blue wave — it was a biomedical blue wave, with several doctors and scientists joining Congress. This moment presents a unique opportunity to remove a major American public health problem. I’m talking about impeaching Health and Human Services Secretary Robert F. Kennedy Jr. once the next Congress begins in January. (Paul Knoepfler, 11/18)
The New York Times: An Elegy For Americans Dying Of Measles
America has officially lost its measles elimination status. (Perri Klass, 11/17)
CNN: Dr. Sanjay Gupta: Benefits Of Vaccines Are A Matter Of Fact
I have started, scratched out and even abandoned the writing of this essay. I couldn’t do it. It wasn’t there. Didn’t feel it. Something kept nagging at me, and it took some time to finally figure out what it was. It’s the idea that this article would be labeled “opinion” or “editorial” in the first place. Sure, there are some topics that seem to lend themselves appropriately to opinion pages. Vaccines, however, which have prevented 6 million deaths every year worldwide and have fundamentally changed modern medicine, should not be on that list. (Dr. Sanjay Gupta, 11/17)
Stat: A Radical Way To Transform Medical Education
Over eight years as an M.D./Ph.D. student, I have watched medical education change considerably. Preclinical curricula have become shorter, lectures have moved online, virtual reality tools have entered anatomy education, and licensing examinations have repeatedly changed. (Alex Serafini, 11/18)
Stat: Sellas Blood Cancer Immunotherapy Succeeds In Clinical Trial
It looks like I was wrong about Sellas Life Sciences and its experimental blood cancer immunotherapy. On Tuesday, Sellas said the therapy, called galinpepimut-S, reduced the risk of death by 41% compared to standard treatment for patients with an advanced stage of acute myeloid leukemia (AML) — an outcome that achieved the main goal of a Phase 3 clinical trial, the company said. (Adam Feuerstein, 11/17)